| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.08B | +16.1% |
| Cost of Revenue | $7.36B | +12.5% |
| R&D Expense | $73.4M | +6.4% |
| SG&A Expense | $667.1M | -1.3% |
| Operating Income | $1.16B | +75.8% |
| Pre-tax Income | $940.4M | +355.2% |
| Income Tax | $85.1M | -45.0% |
| Net Income | $842.9M | +1399.8% |
| EPS (Basic) | $1.96 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.16B | +21.6% |
| Accounts Receivable | $1.32B | +15.9% |
| Inventory | $1.08B | -2.1% |
| Current Assets | $5.47B | +5.2% |
| Total Assets | $9.87B | +2.2% |
| Current Liabilities | $4.86B | +8.9% |
| Long-term Debt | $885.2M | -17.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $961.0M | +38.7% |
| Capital Expenditures | $281.6M | +25.0% |
| Investing Cash Flow | -$75.8M | +39.6% |
| Financing Cash Flow | -$648.0M | +1.3% |
| Free Cash Flow | $679.4M | +45.2% |
| +1407.7% |
| EPS (Diluted) | $1.91 | +1491.7% |
| Total Liabilities |
| $6.73B |
| +3.8% |
| Stockholders' Equity | $3.09B | -1.4% |